Sublocade and Buprenorphine Testing: Why Oral Fluid May Matter After the Last Injection
Case: A 35 years old male with a history of opioid abuse was on Sublocade therapy which ended on January 12. His continued post-Sublocade therapy included laboratory testing for buprenorphine. His results were as follows: Date Urine (ng/mL) Oral Fluid Buprenorphine Norbuprenorphine Buprenorphine Norbuprenorphine 3/25 N/A N/A Neg Neg 4/8 N/A N/A Neg Neg 4/15 […]
Why Iowa’s Prior Authorization Reform Matters for Behavioral Health and Recovery
Iowa House File 2635 (HF2635) is a healthcare reform bill that was passed by the Iowa Legislature and signed by the Governor. The bill states that AI cannot be the sole basis for denying, delaying, or downgrading medically necessary services. Human clinical review remains required. The law is not written only for behavioral health. It […]
7-OH Drug Abuse: The Opioid-Like Product Hiding in Gas Stations and Vape Shops
A new drug trend is creating concern across treatment centers, emergency departments, poison control networks, and clinical toxicology teams. It is called 7-hydroxymitragynine, better known as 7-OH, 7-hydroxy, or 7-OHMG. At first, many people hear “7-OH” and think it is just another kratom product. That is where the confusion begins. The issue is not traditional […]
Mail-backs for Opioid Analgesics Dispensed in Outpatient Settings | FDA
Opioid Use Disorder (OUD) It is one of the biggest public health threats of this era with nearly 50,000 deaths (mostly preventable) from Opioid overdoses only in the US in 2019. Recently, there is an increasing trend of prescription opioid use for the treatment of chronic, non-cancer pain, such as back pain or osteoarthritis, despite serious risks […]
